ArticleBMC cardiovascular disorders2023

Real-world evidence of switching P2Y12 receptor-inhibiting therapies to prasugrel after PCI in patients with ACS: results from EFF-K registry.

Jeehoon Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.